胸腔内注药治疗结核性胸膜炎30例疗效观察

目的：探讨胸腔内注射药物治疗结核性胸膜炎的临床治疗效果。方法：选择我院2008年2月～2010年2月结核性胸膜炎患者60例，将患者随机分为观察组（n=30）和对照组（n=30）。两组患者均给予2SHRZ／4HR抗结核方案治疗，同时给予强的松30mg顿服．服用2周后．逐渐减量，服用6周后停止服用。两组患者均每次抽出胸腔积液800ml左右，胸腔积液抽出后，向胸腔内注射药物，对照组患者注入地塞米松10mg，观察组患者向胸腔注入地塞米松10mg，同时注入异烟肼0．3g。结果：观察组显效率与对照组比较，差异有统计学意义（P〈0．05）；观察组总有效率与对照组比较，差异有统计学意义（P〈0．05）。结论：胸腔内注入地塞米松和异烟肼治疗结核性胸膜炎临床效果显著，值得借鉴。

Clinical observation of drugs injected into intrapleural cavity on 30 cases with tuberculous pleurisy

Objective: To explore the clinical efficacy of drugs injected into intrapleural cavity on tuberculous pleurisy.Methods: 60 cases with tuberculous pleurisy were selected and randomly divided into two groups from February 2008 to February 2010 in our hospital,observation group(n=30) and control group(n=30).The same antituberculous programme was used to two groups,and Prednisone(30 mg) was taken,draught,the dose decreased after two weeks,and stopped after six weeks.About 800 ml pleural effusion was extracted f...